6. Esper AM, Martin GS: Evolution of treatments for patients with acute lung injury. Expert
Opin Investig Drugs 2005; 14: 633–645 7. Matute-Bello G, Liles WC, Radella F 2nd, et al …

Introduction Acute respiratory distress syndrome (ARDS) is a severe form of acute lung
injury common in critically ill patients and characterized by significant morbidity and …

It is generally accepted that neutrophils play a key role in the development of acute
respiratory distress syndrome (ARDS)(1). Chemotactic mediators cause an accumulation of …

Acute respiratory distress syndrome (ARDS) is a frequently encountered clinical syndrome
associated with unacceptably high morbidity and mortality. 1 Since its first description in …

The acute respiratory distress syndrome (ARDS) was initially described as a clinical entity by
Ashbaugh et al.[1], who reported on a group of patients with poor oxygenation, bilateral …

Acute respiratory distress syndrome (ARDS) is a com-plex condition resulting from many
biological pathways. Two recent studies suggest that identification of distinct phenotypes of …

The acute respiratory distress syndrome (ARDS) causes 40% mortality in approximately
200,000 critically ill patients annually in the United States. ARDS is caused by protein-rich …

Over the past decade, unprecedented progress has occurred in the understanding and
management of the clinical problem set that we label as acute lung injury (ALI) and its more …

Despite substantial progress since the initial description of acute respiratory distress
syndrome (ARDS) by Ashbaugh and colleagues in 1967, the pathophysiology of ARDS …

Acute respiratory distress syndrome (ARDS) is a clinical syndrome of inflammatory lung
injury characterized by the acute onset of hypoxemia, noncardiogenic pulmonary edema …